Abstract # 9:

Scheduled for Saturday, September 19, 2009 10:45 AM-10:55 AM: Session 1 (Mission Bay Ballroom AB) Symposium


T. R. Gillespie1,3, I. B. Rwego2, F. H. Leendertz4 and D. Travis5
1Emory University, Global Health Institute and, Department of Environmental Studies, 400 Dowman Drive, E510, Atlanta, Georgia 30322, USA, 2Makerere University, Kampala, Uganda, 3US Centers for Disease Control and Prevention, 4Robert Koch Institute, Berlin, Germany, 5Lincoln Park Zoo, Chicago

Free-ranging primates have long been the focus of surveillance for potential zoonoses such as yellow fever, malaria, and schistosomiasis. However, interest in primate-associated zoonoses has grown dramatically since the HIV/AIDS pandemic was traced definitively to zoonotic transmission of SIV-1 from chimpanzees. Concurrent disease-related threats to primate populations, including exposure to novel pathogens from wildlife reservoirs (i.e., ebola) and mortality-associated transmission of human pathogens (i.e., respiratory viruses), have highlighted the urgency of disease surveillance for primate conservation. Success in addressing such issues at the interface of global health and biodiversity conservation requires cooperation and trust among a diverse group of specialists and stakeholders who often come from divergent backgrounds. Ethical considerations in this "crisis discipline" are underdeveloped. We hope to provide a framework and stimulate discussion toward an integration of ethical principles including animal welfare, biopiracy, confidentiality, euthanasia, informed consent, professional ethics, and medical ethics to facilitate ethical field-based investigations of primate disease.